default author photo

Ding Ma

Huazhong University of Science and Technology - Department of Obstetrics and Gynecology

China

SCHOLARLY PAPERS

4

DOWNLOADS

224

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Evaluation of Multi-Modal Liquid Biopsy as a Diagnostic Tool for High Grade Serous Ovarian Cancer

Number of pages: 37 Posted: 06 Dec 2024
Oregon Health and Science University - Division of Oncological Sciences, Anhui Provincial Hospital, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Chongqing University Cancer Hospital, Zhengzhou University - Department of Gynecology, Huazhong University of Science and Technology - Department of Oncology and Huazhong University of Science and Technology - Department of Obstetrics and Gynecology
Downloads 79 (809,932)
Citation 1

Abstract:

Loading...

High grade serous ovarian cancer diagnosis, High grade serous ovarian cancer referral, cfDNA, DNA methylation profile, cfDNA reduced representation bisulfite sequencing

2.

Spatial Heterogeneity of Infiltrating T Cells in High-Grade Serous Ovarian Cancer Revealed by Multi-Omics Analysis

Number of pages: 77 Posted: 30 Nov 2021
Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Gynecology and Obstetrics, City University of Hong Kong (CityU) - Shenzhen Research Institute, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, City University of Hong Kong (CityU) - Shenzhen Research Institute, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology - Department of Gynecology and Obstetrics, City University of Hong Kong (CityU) - Department of Computer Science, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Oregon Health and Science University - Division of Oncological Sciences, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology and Huazhong University of Science and Technology - Department of Obstetrics and Gynecology
Downloads 56 (1,000,027)

Abstract:

Loading...

TILs, spatial heterogeneity, multiple lesions, multi-omics

3.

Risk Assessment and Triage Strategy of Cervical Cancer Primary Screening On HPV Integration Status

Number of pages: 17 Posted: 04 May 2023
Huazhong University of Science and Technology - Department of Gynecologic Oncology, Huazhong University of Science and Technology - Department of Gynecologic Oncology, Sun Yat-sen University (SYSU) - Department of Gynecological Oncology, Huazhong University of Science and Technology - Department of Epidemiology and Biostatistics, Zhejiang University - Department of Gynecologic Oncology, Huazhong University of Science and Technology - Department of Gynecologic Oncology, Wuhan Central Hospital, Huazhong University of Science and Technology - Department of Gynecology and Obstetrics, Huazhong University of Science and Technology - Department of Gynecology and Obstetrics, Zhejiang University - Department of Gynecologic Oncology, Huazhong University of Science and Technology - Department of Gynecologic Oncology, Huazhong University of Science and Technology - Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Maternal and Child Health and Family Planning Service Center of Longyou County, Huazhong University of Science and Technology - Department of Gynecology and Obstetrics, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - First Affiliated Hospital, Zhejiang University - Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases Women’s Hospital and Huazhong University of Science and Technology - Department of Obstetrics and Gynecology
Downloads 55 (1,010,164)

Abstract:

Loading...

cervical cancer screening, HPV testing, HPV Integration, high-risk HPV, triage strategy

4.

Neoadjuvant Niraparib Monotherapy for Newly Diagnosed Unresectable HRD-Positive High-Grade Serous Ovarian Cancer (NANT): A Multicenter, Prospective, Phase 2 Trial

Number of pages: 31 Posted: 09 Feb 2026
Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Sichuan University, Sun Yat-sen University (SYSU), Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology - Department of Radiology, Huazhong University of Science and Technology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Shandong University, Wuhan University, Sichuan University, Sichuan University, Sichuan University, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, University of California, San Francisco (UCSF), Zai Lab (Shanghai) Co, Ltd., Precision Scientific (Beijing) Co., Ltd., Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Guangdong Academy of Medical Sciences, Huazhong University of Science and Technology - Hubei Cancer Hospital, Independent, Shandong University, Wuhan University - Department of Gynecology and Obstetrics, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology and Huazhong University of Science and Technology - Cancer Biology Research Center
Downloads 34 (1,263,436)

Abstract:

Loading...

Ovarian cancer, neoadjuvant therapy, PARP inhibitor, homologous recombination deficiency